Differential induction of pro- and anti-inflammatory cytokines in whole blood by bacteria: effects of antibiotic treatment. by Frieling, J.T.M. et al.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/25645
 
 
 
Please be advised that this information was generated on 2017-12-05 and may be subject to
change.
A n t i m i c r o b i a l  A g e n t s  a n d  C h e m o th e r a p y ,  Ju ly  1997, p. 1439-1443  
0()66-48()4/97/$()4.00+0
C o p y r ig h t  © 1997, A m e r ic a n  S ocie ty  fo r  M icrobio logy
Vol. 41, No. 7
Differential Induction of Pro- and Anti-Inflammatory Cytokines in
Whole Blood by Bacteria: Effects of Antibiotic Treatment
J. T. M. FRIELING,1 J. A. MULDER,“ T. HENDRIKS,' J. H. A. J. CURFSr C. J. van der
ano R. W. SAUERWEIN2*
1 I
S u rgery i Micr
HB
legen,
Received 21 November 28 Ja n u a ry
The in vitro production of interleukin-lß  (IL-lß), IL-6, and the IL-l receptor antagonist (IL-lra) in whole 
blood upon Stimulation with different bacterial strains was measured to study the possible relationship between 
disease severity and the cytokine-inducing capacities of these strains. Escherichia coli, Neisseria meningitidis, 
Neisseria gonorrhoeae, Bacteroides fragilis, Capnocytophaga canimorsus, Staphylococcus aureus, Enterococcus fae~
, Streptococcus pneumoniae, and Streptococcus pyogenes induced the cytokines IL-lß, IL-6, and IL-lra. 
Gram-negative bacteria induced significantly higher levels of proinflammatory cytokine production than
gram-positive bacteria. These differences were less pronounced for the anti-inflammatory cytokine IL-lra. In 
addition, blood was stimulated with E. coli killed by different antibiotics to study the effect of the antibiotics on 
the cytokine-inducing capacity of the bacterial culture. E, coli treated with cefuroxime and gentamicin induced 
higher levels of IL-lp and IL-6 production but levels of IL-lra production similar to that of heat-killed E. coli. 
In contrast, ciprofloxacin- and imipenem-cilastatin-mediated killing showed a decreased or similar level of 
induction of cytokine production as compared to that by heat-killed E. coli; polymyxin B decreased the level of 
production of the cytokines.
HMntii t tW 'm ' i w i w n f m i  n.i ■ 111^ " i f  1 f t  r* p 5« m< *fv i [>■>*»i  y » p  y i  r * t  > 0  M ra *  u j « i  t o  i  h w vn i w x m —■ ’  i k t n i  t
The introduction of potent antimicrobial agents has in­
creased survival among patients with gram-negative sepsis, but 
mortality still varies between 20 and 50%, especially in patients
cell wall, induce the release of cytokines by peptidoglycans and
teichoic acid (23, 34).
We studied the mor-
with shock (30). This high mortality may be explained by the phologically intact bacteria to induce cytokines in whole blood
reaction of the patient to cell wall components from bacteria,
(LPS), which induces an un-
ammatory m damage
and the clinical severity of the infection. In 
the effect of Escherichia coli treated 
antibiotics on cytokine induction.
a p£
interleukin-I ß  (IL-lß), IL-6, and the anti-infl
kine IL-l antagonist (IL-ln
and organ failure. LPS is released by living and growing bac­
teria, but killing of the bacteria by antimicrobial agents may 
additionally liberate LPS. This may lead to an initial deleteri­
ous effect of antibiotic treatment on the 
tient. Such phenomena have been described for typhoid fever 
(4) and for suspected gram-negative
ported by studies which show increased concentrations of LPS
Upon antibiotic treatment of clinical (21) or experimental ( 1 7 ,  Jmtflis ATCC ¡0584, Staphylococcus aureus ATCC 25293, Enterococcus faecalis
25, 26, 33) infections and in in vitro models (3, 5-7, 12,
MATERIALS ANI) METHODS
The following microorganisms wert* ; coli ATCC 25922,
* *»
The amount of LPS released is by the a n d
ATCC 29212, Streptococcus pneumoniae ATCC 6305, Streptococcus pyogenes 
ATCC 43202, and clinical isolates of Neisseria meningitidis, Neisseria xoitorrltoeue, 
and Capnotytophaga catumomis. Bacteria were cultured in brain heart infusion
T numbers of bacteria were
concentration of the antimicrobial agent as well as the nature
to the required turbidity by
of the bacteria. PI 
correlate with clinical
I
is the
of cytokines through cell wall components like LPS 
which mediates the biological responses during bi
md
to correlate with clinical outcome (8,
measuring the optical density. After dilution the bacteria were killed by X-ray 
irradiation at a dose of 25 kC iy and were added to whole human blood.
Whole-blood stimulation. A modification of the method described bv Dosch el 
al. (9) was used for whole-blood stimulation. Whole blood was drawn from
key role of cytokines is also demonstrated by the 
anti-tumor necrosis factor antibodies to
Herxheimer reaction when 
antibiotic treatment (14). LPS is
healthy hospital employees in a sterile vacuum tube (Sherwood Medical, Bailey
money, Northern Ireland) to which sterile pyrogen-free heparin (Organon Tech 
nika, Boxtel, The Netherlands) was added as anticoagulant at a linai concentra
a w
* »
tion of 50 Ill/ml of Whole blood (0.5 was f* to a sterile
polypropylene tube containing 10 jxl of stimulus or (as a control) 
followed by incubation al 37'*C for 24 h. After incubation were centri
r
a »
wall that induce an
antibodies are given before
one of the bacterial cell
ammatory
fuged and plasma was collected and stored at 20"(’ until it was used.
LPS from E. coli serotype 0 5 5 :B5 (product no. 1,4005; Sigma, St. Louis, Mo.) 
at a final concentration of 10 jig/ml was used in each as a re nee for
(11). Gram-positive >, which lack LPS in
i n whole-blood assay.
»-6
lore (IS). In brief, a %-well plate (Costar 3500 E was coi
overnmht at m 11**6 antibody (BIi-8) and was washed with wash huiler
0.05% Tween 20). Wells were blocked with phosphate
bulle r containing bovi ne serum albumin (product no. to % * a)
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1 h at 37°C.
*iv j.
standard (recombinant IL-6) was i
was repeated, and a second biotinylated antibody to II 
After 1 h of incubation at room temperature, the plate was washed, strcptavidin- 
horseradish peroxidase (product no. S5512; Sigma) was added to the wells for 45
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FIG. 1. Cytokine response (mean ± SD) to 
Results are expressed as the percent 
m 1.
concentrations of LPS. 
to that of 10 |xg LPS per
, IL-lß; ■, IL-6; + , IL-lra.
The level of IL-lra production by 10 fxg of LPS
6 6 ng/ml (m
Cytokine induction by different bacteria. In Fig. 2 the
IL-1 (3, IL-6, and IL-lra donors from
stimulation with 10 |xg of LPS
The concentration of IL-6
84.2
given wt «
by 10 |xg of LPS per ml was
29.5 ng/ml; that of IL-1£ was 35.7 
of IL-lra was 11.9 ± 3.0 ng/ml (means 
nors). Cytokine induction
6 ng/ml and that 
for seven do-
bacteria at a concentration 
0.5 X 10ft CFU/ml could be detected for each bacterial species 
The production of IL-6 and I L~ 1 (3 was significantly higher ir
md C. c
parable to those of the gram-positive bacteria tested.
min, and the plate was subsequently washed. Thereafter, o-phenyldiamine (0.5 
mg/ml; product no. P6912; Sigma) was added, and after 15 to 20 min the color 
reaction was stopped with H 2S 0 4 (2.5 M). The optical density was read at 492 nm
with an automated plate ree Multiskan MCC/340; Labsystems,
Amsterdam, The Netherlands). The detection limit of the assay was 20 pg/ml.
IL-lp  and IL-lra levels were determined by radioimmunoassays 
Recombinant human IL-1 (3 and IL-lra were used as standards. The detection 
limits of the assays varied between each run and were usually between 0.02 and 
0.20 ng/ml.
LPS was detected by a chromogenic Limulus amoebocyte lysate assay (Cont­
est, Chromogenix, Molndal, Sweden) by the endpoint method according to the 
instructions of the manufacturer. The detection limit of the assay was 12.5 pg/ml.
To investigate the effects of antibiotic treatment on cytokine induction in 
whole blood, E. coli ATCC 25922 was cultured for 2.5 h in Trypticase soy broth 
medium to induce logarithmic growth. Subsequently, bacteria were cultured in 
broth at a concentration of 5 x  I(V* bacteria/ml in the presence of antibiotics for
h . it i. c mor intact microorganisms on
Gram staining were used as controls. After incubation the antibiotic-treated E.
coli samples were tested in the whole-blood assay. The final concentration in 
whole blood was I05 bacteria/ml.
The final concentrations of the antibiotics used were as follows: ciprofloxacin, 
4 jjLg/ml (Bayer, Mijdrecht, The Netherlands); cefuroxime, 80 jxg/ml (Glaxo, 
Zeist, The Netherlands); gentamicin, 10 jxg/ml (Schering-Plough, Weesp, The 
Netherlands); imipenem-cilastatin, 50 ng/ml (Merck Sharp & Dohme, Haarlem, 
The Netherlands); and polymyxin B, 15 |xg/m 1 (Pfizer, Capelle a/d IJssel, The
Netherlands). These concentrations were based on the peak levels in human 
plasma during treatment with a standard intravenous dose. Antibiotic concen­
trations exceeded the MICs by >40 times in all cases.
Statistical analysis. One-way analysis of variance was used for statistical anal-
ysis. Comparisons between bacteria and antibiotics were calculated by the New 
man-Kculs test. A P value of • 0.05 was considered statistically significant.
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response to LPS in whole blood. Figure I shows the
in IL-ip and IL-6 concentrations 
addition of LPS to the whole-blood system. An LPS
concentration of > 0 .1 ng/ml was required for the induction of
IL-lß and IL-6. The of production of IL-lß in
donors induced by 10 jxg of LPS per ml was 55.3 ± 20.0 ng/ml, 
and the level of IL-6 production was 26.8 ± 12.5 ng/ml (values
of± standard deviations [SDS]). In the 
LPS there was some constitutive presence of IL-lra at 1.2 to 
3.6 ng/ml, but no constitutive production of IL-1 (3 or IL-6 was 
detectable. An increase in the level of IL- l ra production could 
already be achieved by 20 pg of LPS per ml. The maximum
of IL-lra production in whole blood was obtained with
roughly 1.0,000-fold lower concentrations of LPS than
required for the maximum of IL-lß and IL-6 production.
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TABLE 1. Cytokine induction by antibiotic-killed E. coli
Antibiotic
% Cytokine induction1a
IL-lß IL-6 IL-Ira
Cefuroxime 282.6 ±  28.4 177.4 ±  46.3 104.4 ±  9.2
Gentamicin 145.4 ± 1 1 . 2 143.3 ±  32.0 114.9 ±  8.9
Ciprofloxacin 86.8 ±  10.3 88.9 ±  13.6 108.8 ±  10.1
Imipenem 88.4 ±  40.1 87.5 ±  9.4 100.8 ±  6.4
Polymyxin B 25.8 ±  4.2 14.6 ±  7.6 65.6 ±  20.7
ANOVA6 < 0 .0 0 0 1c 0.0002'' 0.003*
a Values are means ±  SDs of three tests. Values are expressed as the percent­
age of induction compared to that by heat-killed E. coll 
b NOVA, analysis of variance.
r By the Newman-Keuls test, P <  0.05; comparisons were significantly different 
except ciprofloxacin versus imipenem.
ll By the Newman-Keuls test, P < 0.05 for cefuroxime versus ciprofloxacin and 
imipenem and polymyxin B versus all other antibiotics. 
f’ Newman-Keuls test, P <  0.05 for polymyxin B versus all other antibiotics.
amoebocyte lysate assay activity than cefuroxime, followed by 
ciprofloxacin and imipenem. Polymyxin B treatment of E. coli 
resulted in hardly any increase in Limulus amoebocyte lysate 
assay activity; however, polymyxin B interfered with the Limu- 
lus amoebocyte lysate assay.
In order to get an impression of the fraction of LPS that is 
bound to the bacteria and the fraction that is free, cultures
j
were filtered through a sterile pyrogen-free 40-jxm-pore-size 
filter. Figure 3 shows the increase in Limulus 
lysate assay activity for antibiotic-treated E. c o m p c
the Limulus Amoebocyte lysate assay activity for the heat-killed 
E. coli for both total and free LPS. The LPS concentration in 
the heat-killed E. coli was 1.9 X 105 pg/ml, and after filtration 
it was 7.8 X 105 pg/ml. The fraction of free LPS
after cefuroxime treatment and came into
*
total amount of LPS after treatment with the other antibiotics,
i
although the total amount was still higher.
Induction of cytokines by antibiotic-killed E. colL The cul­
tures of E. coli were killed by the tested antibiotics within 1 to 
18 h. This was determined by subculturing. To ascertain that all 
bacteria were killed, the experiments were performed after 
incubation of the cultures with the antibiotics for 24 h.
At the concentrations used in this study, the antibiotics ce­
furoxime, gentamicin, ciprofloxacin, and imipenem did not in­
fluence the LPS-induced production of IL-1(3, IL-6, and IL-lra 
in whole blood. Polymyxin B did significantly reduce the in­
duction of cytokines by LPS (data not shown).
Table 1 presents the results of IL-6, IL-lp, and IL-lra in­
duction by antibiotic-killed E. coli. IL-lp production by the 
heat-killed E. coli was 22.0 ± 13.9 ng/ml, IL-6 production was 
54.5 ±31.6 ng/ml, and IL-lra production was 14.8 ± 2.0 ng/ml
(means « a j a * SDs).
The levels of IL-6 and IL-lp induction by antibiotic-treated 
E. coli differed significantly among the antibiotics used. Com­
pared to heat-killed E. coli at 105 CFU/ml, cefuroxime-treated 
E. coli induced a significant increase in IL-6 and IL-ip pro­
duction. Gentamicin treatment also led to increased IL-ip and 
IL-6 induction, although the increase in IL-6 induction was not 
significant. Ciprofloxacin and imipenem killed the bacteria 
without significantly increasing the level of induction of IL-6 
and IL-lp. Treatment of E. coli with polymyxin B resulted in a 
decrease in the levels of both IL-6 and IL-lp induction. The 
level of IL-lra production was little influenced by antibiotic 
killing except for that by polymyxin B.
The level of production of IL-ip induced by cefuroxime- and 
polymyxin B-treated E. coli differed significantly from the level 
of production induced by heat-killed E . coli. Differences be­
tween antibiotics in the induction of IL-1(B production were 
significant for all antibiotics except imipenem versus cipro­
floxacin. Differences between antibiotics in IL-6 induction ca­
pacity were not significant for gentamicin versus ciprofloxacin, 
cefuroxime, and imipenem and were not significant for imi­
penem versus ciprofloxacin. For IL-lra induction capacity, 
only the differences between polymyxin B versus heat-killed E. 
coli and the other antibiotics were significant.
Effect of antibiotic treatment of E. coli on the LPS concen­
tration. The activity of the suspension of heat-killed E. coli in 
the Limulus amoebocyte lysate assay (Fig. 3) was lower than
that of the suspension of antibiotic-treated E. coli (10 CFU/ 
ml). Cefuroxime treatment gave the highest increase in Limu­
lus amoebocyte lysate assay activity among the antibiotics 
tested. Gentamicin resulted in less of an increase in Limulus
DISCUSSION
In this study we investigated the production in whole blood 
of the pro inflammatory cytokines IL-1(B and IL-6 and the 
inflammatory cytokine IL-lra stimulated by a number of bac­
teria. Major differences were found between gram-negative 
and gram-positive bacteria in the induction of IL-1|3, IL-6, and 
IL-lra production in whole blood. The higher levels of pro­
duction of cytokines induced by gram-negative bacteria might 
indicate that in gram-negative infections high levels of cytokine 
induction lead to a more acute and fulminant clinical picture 
compared to that in infections with gram-positive bacteria. 
Although gram-positive organisms are capable of inducing cy­
tokine production, 100- to'1,000-fold more gram-positive bac­
teria are needed to induce the same concentration of cytokines
induced by gram-negative bacteria. gram-negative
ganisms are more potent inducers of IL-ip, IL-6, and IL-lra
than gram-positive bacteria in the whole-blood assay, which
confirms the studies with isolated monocytes 
Timmerman et al. (34) and Mattson et al. (23).
The relation between the capacity to induce 
duction in the whole-blood assay and disease
by
pro-
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increase in Limulus amoebocyte lysate assay activity compared to the activity of 
the same amount of heat-killed E. coli. CXM, cefuroxime; GM, gentamicin; ( 
ciprofloxacin; IPM, imipenem-cilastatin; and Poly-B, polymyxin B.
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obvious for the individual bacterial strains. Gram-negative sep- production. This probably results from the fact that the IL-lra
sis caused by N. meningitidis is a fulminant disease with a high production induced by LPS is about 10,000-fold more efficient
mortality rate which may be 
ity to induce a strong cytokine r 
In contrast, N. gonorrhoeae 
to that of N. meningitidis in our s
by the organism’s
in our in vitro
than the IL-1(3 production induced by (rig- With high
canimorsus
induction capacity similar 
, but bacteremia with N. 
with mild clinical symptoms. Similarly, C 
very low level of production
concentrations of bacteria, the production capacity of IL-lra is 
already on a plateau and neither an 
crease in cytokine-inducing 
in
nor a small de­
can result in a change 
level of IL-lra production. At lower concentrations of
r - ' ...  /• z'"» v y m 3  A'ir-'T t /— r \  <.u ~ -------- J . . . f  TT 1 ....
1 l - j - 11  dE. coli (2 X IO'1 CFU/ml), the
but can induce a very serious clinical picture of sepsis with a shows a pattern similar to those for IL-lp and IL-6 (data not 
high mortality rate (2). The reason for this inconsistency might
be the anatomical location of the infection (e.g., in the central The modified ex vivo cvtokine production model that is used
of toxins (e.g., by C. canimorsus is a good
•erices in action of cefuroxime, gen
tamicin,
differences in inducing cytokine production by 
E, coli. Imipenem makes the b
oxime, also a (3-lactam
in
<
tiori of intercellular septa in dividing bacteria
(28). In the 
wall components are formed
may assume that
is
by the high levels of IL-ip and IL-6 production. Dofferhof et 
al. (10) also found that killing of E. coli by cefuroxime induced 
higher levels of production of tumor necrosis factor in isolated 
monocytes compared to that induced by E. coli killed with 
other antibiotics. In their tests, killing of E. coli with imipenem 
also resulted in the lowest level of induction of tumor necrosis 
factor, and the highest level of production was achieved with E. 
coli killed with cefuroxime. The LPS concentration found in 
the cultures with cefuroxime-killed bacteria also indicates the 
formation of more cell wall mass. The large difference between 
the amounts of total and free LPS with cefuroxime-treated E. 
còli might indicate that most of the LPS is constituted in the 
filaments which might not pass through the filter. Gentamicin
acts on DNA; o n
gyrase 
cell wall 
micin killing
to a minimal change in 
s. In the study of Prins et
I *L. can in
production than was used. In our í
IL-lß  and IL-6. The explanation Prins et
give is * ic mac
LPS (1, 16). The addition of LPS to in the pres
; production, leaving
anation
ported by the finding that the i 
cultures was almost equal to that
of LPS measured in the 
in cultures of bacteria
I *i n -
i last two antibiotics was
wav
kills the bacteria by changing the osmotic barrier. The major 
reason for the low level of induction of cytokines is the binding
in B to LPS, which > i n a
in our
Limulus
capacity but also
i n
assay.
of LPS in
e, no answer
m u c h
oli by poly
1 were
B-treated E. coli induced a lower
arge;
models that h
in
this changes 
small
is used, but
that a
cytokines IL-ip, IL-6, and IL-lra when the blood is 
The anticoagulant that is used also influences the cy
Maximum
by the use of endotoxin-free heparin (data not shown).
The results of this study in agreement with findings by
others with respect to LPS release by antibiotic-killed bacteria 
(10, 29, 37). However, this study shows that there is 
ancy the concentrations of LPS 
amoebocyte lysate assay and the induction of cyto-
in whole blood. than LPS,
other cytokine-inducing products derived from killed b< 
or even the drugs administered, could be responsible for this 
discrepancy. Clinical studies with humans should be 
see whether the differences between antibiotics seen in 
blood are clinically relevant. Since the differences between the
induction of
cannot always predict 
be even more essential.
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clinical to
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